1. Home
  2. CDNA vs DGII Comparison

CDNA vs DGII Comparison

Compare CDNA & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.47

Market Cap

712.2M

Sector

Health Care

ML Signal

HOLD

Logo Digi International Inc.

DGII

Digi International Inc.

HOLD

Current Price

$44.47

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
DGII
Founded
1998
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
712.2M
1.5B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
CDNA
DGII
Price
$19.47
$44.47
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$26.67
$46.80
AVG Volume (30 Days)
782.3K
317.3K
Earning Date
11-04-2025
02-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.05
EPS
1.22
1.08
Revenue
$357,998,000.00
$430,221,000.00
Revenue This Year
$14.11
$10.51
Revenue Next Year
$11.75
$8.01
P/E Ratio
$16.24
$40.88
Revenue Growth
14.46
1.46
52 Week Low
$10.96
$22.39
52 Week High
$25.95
$48.00

Technical Indicators

Market Signals
Indicator
CDNA
DGII
Relative Strength Index (RSI) 58.23 58.39
Support Level $19.01 $43.28
Resistance Level $20.61 $44.59
Average True Range (ATR) 0.80 1.25
MACD -0.11 -0.34
Stochastic Oscillator 45.12 24.15

Price Performance

Historical Comparison
CDNA
DGII

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.

Share on Social Networks: